DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
77 hedge funds and large institutions have $497M invested in DIPLOMAT PHARMACY, INC. in 2014 Q4 according to their latest regulatory filings, with 77 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$120M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$46.1M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$29.3M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$24.9M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$22.8M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| $5K | +$4.85K | +200 | New |
|
77
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $98 | +$87.3K | +3,598 | New |
|
DPLO Hedge Fund Activity: Q4 2014 in Review
77 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2014, worth a combined $497M.
Buyers outnumbered sellers: 77 funds opened new DPLO positions and 0 closed out — a net gain of 77 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $120M.
- 77 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $497M of DIPLOMAT PHARMACY, INC. stock for Q4 2014.
- 77 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2014 and 0 closed out, a net change of +77 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2014 was T. Rowe Price Associates, an estimated $120M added.
Based on aggregated 13F filings for Q4 2014.